!!Xin Lu - Curriculum Vitae \\ __Education:__ \\ *1991 PhD in Cell and Molecular Biology, Imperial Cancer Research Fund and University College London, London, UK\\ *1985 MSc in Cell and Molecular Biology, Cancer Institute, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, P. R. China\\ *1982 BSc in Biochemistry, Sichuan University, P.R. China \\ __Committees and Associations:__ \\ \\ __1. Scientific Advisory and Selection Committees:__ \\ *2021 Istituto Toscano Tumori (ITT) Italy ISAB member\\ *2010 - present Medical Sciences Division Board Member, University of Oxford, UK\\ *2013 - present Academy of Medical Sciences, Selection Committee \\ *2011 Carcinogenesis Prize Selection Committee, UK\\ *2010 Molecular Medicine Advisory/Review Panel Member, The Nordic Centre of Excellence Programme\\ *2008 - 2010 Scientific Advisory/Review Board Member, Institute of Molecular and Cell Biology, Singapore \\ *2006 - 2009 Advisory Panel Member, CR-UK China Fellowships Programme, UK \\ __2. Institute Review Committees__ \\ *2020 The ‘Genes and Society’ and ‘Neuroscience’ Research Themes Review for Trinity College Dublin\\ *2014-2016 International Review, Peking University School of Life Sciences, China\\ *2010-present International Review, Tsinghua University, China \\ *2009 MRC Epigenetics, Development and Cancer Section, Imperial College, London, UK\\ *2008-present International review, Chinese Academy of Science, China\\ *2008 MRC Induced Pluripotent Stem Cells Review Board, UK\\ *2008 MRC Models of Disease Panel, UK\\ *2008 MRC Genome Damage and Stability Centre Review, UK\\ *2008 Cesar Milstein Chair Electoral Board, University of Oxford, UK\\ *2007 - 2008 MRC Oncology Showcase Pilot Industry Collaboration Award Scheme, UK \\ __3. Grant Committees__ \\ *2020 Swedish Research Council Review Panel for “Grants for Distinguished Professors”\\ *2012 - present European Research Council (ERC) Consolidator Panel\\ *2011 - 2015 Cancer Research UK New Investigator Awards Panel, UK\\ *2007 Committee Member, Deutsche Forschungsgemeinschaft (DFG), Center of Excellence, Germany\\ *2006 - 2011 MRC Molecular and Cellular Medicine Board (MCMB), UK \\ *2006 - 2009 Chair of Cancer Biology Review Panel, Academy of Finland\\ *2006 - 2009 Several International PhD Examination Committees in Lausanne and Stockholm\\ *2006 Hong Kong Research Council Biomedical Panel, China\\ *2005 - 2006 Chairman, Chinese Life Science Society in UK, UK\\ *2004 - 2007 Scientific Grant Committee Member, Association for International Cancer Research (AICR), UK \\ __4. Editorial Board Memberships:__ \\ *2014 - present Cell Death and Differentiation, Receiving Editor\\ *2009 - present Cell Death and Disease, Editorial Board Member \\ *2008 - present Oncogene, Receiving Editor\\ *2008 - 2011 Carcinogenesis, Editorial Board Member \\ *2005 - 2011 Cell Research, Editorial Board Member \\ __5. Meetings Organised (2007-2016):__ \\ *2016 National Cancer Research Institute (NCRI) Conference Committee Member \\ *2016 Nature Conference, Nuclear Reprogramming and the Cancer Genome, San Diego\\ *2015 ICG-10: the 10th International Conference of Cancer Genomics, Shenzhen \\ *1st CRUK International Oesophageal Cancer Symposium\\ *2014 Chinese Academy of Sciences-Nature Conference: Nuclear Reprogramming and Cancer Epigenetics, Guangzhou \\ *Joint Conference of ICG-9 and the 3rd Shenzhen International Biotechnology Innovation Forum & Expo, Shenzhen \\ *Single Cell Sequencing Workshop, Oxford, UK \\ *2013 Ludwig-Nature Conference: Nuclear Reprogramming of the Cancer Genome, Oxford, UK \\ *2011 Cell Polarity in Health and Disease, Oxford, UK\\ *3rd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\ *2010 2nd Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\ *2008 14th International p53 Workshop, Shanghai, China\\ *Chinese Academy of Science – Morningside Symposium, Kunming, China\\ *Keystone Symposium – Stem Cells, Cancer and Ageing, Singapore \\ *1st Sino-British Frontier Workshop of Cancer Biology, Shanghai, China\\ *2007 University of Oxford Medical Sciences Division, Science Day, Development, Differentiation & Malignancy, Oxford, UK\\ *Mdm2 Workshop, Boston, USA \\ __Patents:__ \\ *LUD5649 Suppressor Genes 04/8/00\\ *LUD5868 iASPP 07/10/02 \\ *LUD5829 iASPP Polypeptide 07/10/02\\ *LUD6098 iASPP Phosphorylation and Metastatic Potential 03/02/12\\ \\